The bcl-2 oncogene and apoptosis

Area of Science:

• Molecular biology
• Cancer research
• Immunology

Background:

• The bcl-2 oncogene is frequently activated by the t(14;18) chromosomal translocation in human follicular lymphomas.
• The bcl-2 protein is known to inhibit apoptosis, a programmed cell death process, across various experimental systems.
• While associated with the inner mitochondrial membrane, the precise biochemical function of bcl-2 remains elusive.

Purpose of the Study:

• To investigate the role of the bcl-2 oncogene and its protein product in apoptosis and cellular survival.
• To explore the in vivo functions of bcl-2, particularly in the context of B cell development and thymic education.
• To understand the implications of bcl-2 dysregulation in human cancers and its potential interaction with other tumor suppressors like p53.

Main Methods:

• Analysis of the t(14;18) chromosomal translocation in human follicular lymphoma samples.
• In vitro and in vivo experiments to assess the anti-apoptotic function of bcl-2.
• Biochemical studies to determine the function of the bcl-2 protein.
• Generation and study of transgenic mice overexpressing bcl-2.

Main Results:

• The bcl-2 oncogene's activation is linked to follicular lymphoma development.
• Experimental evidence confirms bcl-2's potent inhibition of apoptosis.
• Transgenic mice studies demonstrate bcl-2's function as an intracellular survival factor in memory B cells and during thymic education.
• Potential alterations in other apoptosis regulators, like the p53 tumor suppressor gene, are implicated in human tumorigenesis.

Conclusions:

• The bcl-2 oncogene plays a critical role in preventing apoptosis, contributing to lymphomagenesis.
• Bcl-2 acts as an intracellular survival factor, influencing immune cell development and homeostasis.
• Further research into apoptosis regulators like p53 is crucial for understanding cancer development.